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Poly (Amidoamine) Dendrimers
 Defined mass, size, shape and surface chemistry
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I. Influence of surface charge and size
II. Effect of hydrophobic drug loading
III. Transport mechanisms of PAMAM
NH3
























1° – Mouse anti-occludin





aReported by the manufacturer, Dendritech, Inc., Midland, MI
bLabel content is reported as mean ± SD (n = 3)
Kitchens et al., Pharm Res, (2006)
Generation Surface Group # Surface Groups MW (Da)
a Label Content 
(mmol FITC / g dendrimer)b
G2 -NH2 16 3,256 0.3896 ± 0.0288
G2 -OH 16 3,272 0.0604 ± 0.0001
G1.5 -COOH 16 2,935 0.0447 ± 0.0008
G2.5 -COOH 32 6,266 0.0016 ± 0.0001
G3.5 -COOH 64 12,928 0.0044 ± 0.0003
G4:FITC (1:1) -NH2 64 14,215 0.0520 ± 0.0004
G4:FITC (1:4) -NH2 64 14,215 0.2179 ± 0.0020
G4:FITC (1:8) -NH2 64 14,215 0.4148 ± 0.0090



































Mean ± SD (n = 3)








Kitchens et al., Pharm Res, (2006)
Permeability across Caco-2 
Cell Monolayers
Mean ± SEM (n = 9)
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Kitchens et al., Pharm Res, (2006)





























Mean ± SEM (n = 9)
** Toxic (WST-1 assay)
* P < 0.05, increase in Papp
Mannitol     G2OH      G2OH- G1.5        G1.5- G2NH2     G2NH2- G4NH2    G4:FITC








Kitchens et al., Pharm Res, (2006)
Influence of PAMAM on Tight 
Junction Protein Occludin
*34.2 ± 13.4% *14.4 ± 4.0%








0.40 µm z-step size
Kitchens et al., Pharm Res, (2006)
Mean ± SD
(n = 3)
* P < 0.05,
increase
in signal
Bars = 100 µm
Influence of PAMAM on Tight 
Junction Protein Actin
*36.1 ± 3.5% 13.1 ± 6.8%








* P < 0.05,
increase
in signal
Bars = 100 µm
Kitchens et al., Pharm Res, (2006)
60x oil objective
100 µm pinhole
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14C-Paclitaxel Permeability G2 Permeability
– G2
+ G2
– Paclitaxel  
+ Paclitaxel  




































G2                                    Mannitol
Permeability w/Palmitoyl Carnitine
– PC  










1° - Antibodies against 
endocytosis markers
2 ° - Alexa Fluor 568 
goat anti-mouse IgG
LysoTracker Red




Mx = 80.3 ± 3.1%
Mx = 74.3 ± 5.2%
Mx = 70.8 ± 3.9%
FITC Clathrin Merge
Mean ± SEM (n = 6)









Mean ± SEM (n = 6)
Bars = 5 µm
Mx = 63.9 ± 7.3%
Mx= 37.3 ± 5.9%
Mx = 58.7 ± 2.0%
Colocalization with LAMP-1
20 minutes
Mean ± SEM (n = 6)
Bars = 5 µm
Mx = 83.4 ± 0.2%
Mx = 73.7 ± 3.8%
Mx = 75.3 ± 11.2%
Clathrin
Mx = 57.0 ± 8.6%
Mx = 59.0 ± 5.2%








Colocalization: Clathrin & LAMP-1
60 minutes
Control
G3.5COOH (1mM)G4NH2 (1 mM)
G1.5COOH (1 mM)G2NH2 (1 mM)
PAMAM Effect on Microvilli
12,500x Magnification
Bars = 1 µm Generation-dependent effect
G4NH2 (1 mM)G4NH2 (0.01mM) G4NH2 (0.1 mM)Control
G4NH2 Effect on Microvilli
12,500x Magnification
Bars = 1 µm
Concentration-dependent effect
Conclusions
 Cationic and large generation dendrimers had 
greater permeability than anionic and neutral
 Hydrophobic “drug” loading reduced toxicity 
and enhanced permeability
 PAMAM dendrimers modulate tight junctions
 PAMAM dendrimers colocalize with endocytosis 
markers
 Cationic dendrimers cause cytotoxicity by 
compromising microvilli integrity
Design dendrimers for optimized oral drug delivery applications
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